BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1265 related articles for article (PubMed ID: 21467131)

  • 1. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.
    Maas RJ; van den Brand JA; Waanders F; Meijer E; Goor van H; Peters HP; Hofstra JM; Wetzels JF
    Ann Clin Biochem; 2016 Jan; 53(Pt 1):51-7. PubMed ID: 25762211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
    Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of NGAL staining in patients with IgA nephropathy.
    Yavas H; Sahin OZ; Ersoy R; Taşlı F; Gibyeli Genek D; Uzum A; Cirit M
    Ren Fail; 2013; 35(4):472-6. PubMed ID: 23413884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA; Köttgen A; Coresh J; Astor BC
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
    Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.
    Xu PC; Zhang JJ; Chen M; Lv JC; Liu G; Zou WZ; Zhang H; Zhao MH
    Nephrol Dial Transplant; 2011 Oct; 26(10):3229-36. PubMed ID: 21402675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
    Morrissey JJ; London AN; Lambert MC; Kharasch ED
    Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
    van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB
    Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
    Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
    Wang L; Pu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
    Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P
    Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
    Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
    J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.